These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 17181924

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M, Kremer J.
    Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
    [Abstract] [Full Text] [Related]

  • 3. Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
    Lee YH, Bae SC.
    Rheumatol Int; 2016 Nov; 36(11):1591-1599. PubMed ID: 27379764
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study.
    Dervieux T, Furst D, Lein DO, Capps R, Smith K, Caldwell J, Kremer J.
    Ann Rheum Dis; 2005 Aug; 64(8):1180-5. PubMed ID: 15677700
    [Abstract] [Full Text] [Related]

  • 7. Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients?
    Salazar J, Moya P, Altés A, Díaz-Torné C, Casademont J, Cerdà-Gabaroi D, Corominas H, Baiget M.
    Pharmacogenomics; 2014 Jun; 15(8):1079-90. PubMed ID: 25084201
    [Abstract] [Full Text] [Related]

  • 8. Association of MDR1 C3435T and RFC1 G80A polymorphisms with methotrexate toxicity and response in Jordanian rheumatoid arthritis patients.
    Samara SA, Irshaid YM, Mustafa KN.
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):746-55. PubMed ID: 25074866
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients.
    Lima A, Seabra V, Bernardes M, Azevedo R, Sousa H, Medeiros R.
    PLoS One; 2014 Sep; 9(10):e108165. PubMed ID: 25279663
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients.
    Singh A, Gangadharan H, Gupta V, Patro PS, Misra R, Aggarwal A.
    Int J Rheum Dis; 2021 May; 24(5):654-662. PubMed ID: 33780152
    [Abstract] [Full Text] [Related]

  • 13. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Kumagai K, Hiyama K, Oyama T, Maeda H, Kohno N.
    Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. ATIC missense variant affects response to methotrexate treatment in rheumatoid arthritis patients.
    Kurzawski M, Malinowski D, Szarmach N, Nowak A, Goryniak A, Pawlik A, Droździk M.
    Pharmacogenomics; 2016 Dec; 17(18):1971-1978. PubMed ID: 27885916
    [Abstract] [Full Text] [Related]

  • 16. Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.
    Lima A, Monteiro J, Bernardes M, Sousa H, Azevedo R, Seabra V, Medeiros R.
    Biomed Res Int; 2014 Dec; 2014():368681. PubMed ID: 24967362
    [Abstract] [Full Text] [Related]

  • 17. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.
    Wessels JA, van der Kooij SM, le Cessie S, Kievit W, Barerra P, Allaart CF, Huizinga TW, Guchelaar HJ, Pharmacogenetics Collaborative Research Group.
    Arthritis Rheum; 2007 Jun; 56(6):1765-75. PubMed ID: 17530705
    [Abstract] [Full Text] [Related]

  • 18. The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients.
    Nomair AM, Abdelati A, Dwedar FI, Elnemr R, Kamel YN, Nomeir HM.
    Clin Rheumatol; 2024 Mar; 43(3):971-983. PubMed ID: 38311638
    [Abstract] [Full Text] [Related]

  • 19. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.
    Plaza-Plaza JC, Aguilera M, Cañadas-Garre M, Chemello C, González-Utrilla A, Faus Dader MJ, Calleja MA.
    OMICS; 2012 Nov; 16(11):589-95. PubMed ID: 23095111
    [Abstract] [Full Text] [Related]

  • 20. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.
    Sala-Icardo L, Lamana A, Ortiz AM, García Lorenzo E, Moreno Fresneda P, García-Vicuña R, González-Álvaro I.
    Reumatol Clin; 2017 Nov; 13(6):318-325. PubMed ID: 27751863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.